Life Science News
Latest updates from the biotech and pharma world
FDA ‘proactively’ hands J&J a voucher; Pfizer issues 2026 forecasts
Pfizer, Sanofi pull out checkbooks for separate year-end autoimmune pacts
Pfizer adds heft to obesity pipeline in $2B Yaopharma deal
Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
Pfizer dips into China for another try at an obesity pill
OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability
Bio/Pharmaceutical Outsourcing Report, October 2025 - Pfizer and Roche Place $10 Billion Bets on Obesity and Liver Disease Therapies as Trump Tightens Grip on Drug Pricing and Manufacturing - Yahoo Finance
Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen
Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic
Pfizer-allied molecular glue startup Triana collects $120M Series B
Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug
Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3
#mRNA flu#Pfizer mRNA#flu vaccine#greater efficacy#greater effectiveness
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire
#Therapeutic Innovations#Forecast Report#Featuring Lonza#Novo Nordisk#Market Therapeutic